The Role of Flow Couplers in Free Flap Monitoring: Evidence From a Systematic Review and Meta-analysis Authors: Laura De Pellegrin, Léna G. Dietrich, Marcus Wölffer, Radu Olariu, Cédric Zubler, Ioana Lese Published: 2026 ABSTRACT Background:Flow couplers (FCs) are increasingly used in microsurgical free tissue transfer to provide continuous, real-time monitoring of venous outflow at the anastomotic site. This systematic review and meta-analysis evaluates the clinical performance of FCs, focusing on diagnostic accuracy and flap outcomes compared with conventional monitoring techniques.Methods:A systematic search of PubMed, Web of Science, and the Cochrane Library was conducted through November 1, 2025, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Clinical studies reporting FC use in free flap reconstruction were included. Data on flap survival, venous thrombosis, complications, and FC diagnostic performance were extracted. Meta-analyses were performed to calculate pooled sensitivity, specificity, and flap failure rates.Results:Eleven studies including 1775 free flaps (876 monitored with FCs) met inclusion criteria. Pooled sensitivity and specificity for detecting flap compromise were 96.5% and 90.9%, respectively. Flap failure occurred in 2.2% of FC-monitored flaps versus 3.1% in controls. FCs showed a high negative predictive value but variable positive predictive value, with false-positive signal losses being frequently caused by technical issues rather than true thrombosis. False negatives were uncommon. Compared with traditional monitoring methods, FCs provided superior continuous venous assessment.Conclusions:FCs are highly sensitive tools for early detection of venous compromise in free flap surgery, particularly in buried reconstructions. However, limited specificity and inability to detect arterial insufficiency support the use of multimodal monitoring strategies. Standardized protocols and technical expertise are essential to minimize false positives and optimize flap monitoring outcomes. Takeaways Question: Do venous flow couplers reliably detect early vascular compromise in microsurgical free flaps, and does their use improve flap outcomes compared with traditional monitoring methods? Findings: In a systematic review and meta-analysis of 11 studies involving 1775 flaps, flow couplers demonstrated high sensitivity (96.5%) and specificity (90.9%) for detecting venous compromise and showed slightly lower flap failure rates than non–flow-coupler monitoring. False positives were common, largely due to technical factors, whereas false negatives were rare. Meaning: Flow couplers provide highly sensitive venous monitoring but require multimodal assessment due to the current limited specificity. INTRODUCTION Microvascular free tissue transfers have become a foundational technique in reconstructive surgery, providing reliable functional and aesthetic outcomes across a diverse array of clinical indications.1 Versatility and success of these techniques have significantly expanded the reconstructive options available to surgeons. However, the viability of free flaps remains critically dependent on maintaining adequate perfusion, particularly during the early postoperative period.1 Vascular compromise, whether arterial or venous, can rapidly lead to flap ischemia and subsequent tissue necrosis if not identified and addressed in a timely manner.2 Therefore, early detection and prompt surgical intervention are paramount for successful flap salvage and overall reconstructive success.3 Historically, postoperative flap monitoring has relied mainly on clinical observation—such as skin color, capillary refill, turgor, and temperature—and the use of handheld Doppler sonography to assess vascular flow; these and other flap monitoring methods described in the literature are summarized in Table 1.4–6 Although these methods are relatively accessible and cost-effective, their effectiveness is significantly influenced by the experience and skill of the observer.7–9 Furthermore, clinical signs of vascular compromise may be delayed or subtle, and intermittent Doppler assessments can miss transient or rapidly progressing vascular events. These limitations have long stimulated the search for more reliable, objective, and continuous monitoring modalities that can alert the clinical team to early signs of flap compromise.5 Table 1.Free Flap Monitoring ModalitiesMonitoring ModalityInvasivenessMonitoring PrincipleKey AdvantagesKey LimitationsTypical Clinical RoleClinical examinationNoninvasiveVisual and tactile assessment (color, capillary refill, turgor, temperature)Cost-effective, universally available, assesses arterial and venous statusOperator-dependent, subjective, limited in buried flapsGold standard; first-line monitoringHandheld DopplerNoninvasiveAudible detection of superficial arterial/venous flowPortable, inexpensive, easy to useFalse positives, limited depth, not reliable for buried flapsAdjunct to clinical examinationSurface temperature monitoring/thermographyNoninvasiveSkin temperature changes reflecting perfusionBedside use, inexpensive, trend monitoringAmbient sensitivity, indirect perfusion assessmentAdjunctive toolNear-infrared spectroscopyNoninvasiveTissue oxygen saturation (StO2)Continuous, operator-independentHigh cost, variable thresholds, limited buried flap utilityAccording to the literature indicated in selected cases, adjunct in high-risk casesLaser Doppler flowmetryNoninvasiveMicrocirculatory blood flow via light scatterContinuous trend dataExpensive, relative values only, not suitable for buried flapsAdjunctive monitoringImplantable Doppler probeInvasiveDirect ultrasonic flow detectionContinuous monitoring, useful in buried flapsProbe displacement, infection risk, false positivesHigh-risk or buried flapsFlow couplerInvasiveContinuous venous outflow monitoring at anastomotic siteHigh sensitivity, high negative predictive value, ideal for buried flapsModerate specificity, false-positive signal loss, cost, venous-only monitoringBuried or high-risk flaps within a multimodal strategyFluorescence angiography (indocyanine green)InvasiveNear-infrared fluorescence perfusion imagingHigh spatial resolution, useful for intraoperative assessmentHigh cost, intermittent, dye-related limitationsIntraoperative decision-makingMicrodialysis/biochemical sensorsInvasiveMetabolic markers (lactate, glucose, pH)Early detection of ischemiaCostly, invasive, false positives, limited availabilityResearch uses/selected cases Free Flap Monitoring Modalities In this context, implantable Doppler flow couplers (FCs) have emerged as a promising technological advancement. These devices integrate microvascular anastomosis with continuous, real-time Doppler-based flow monitoring, enabling direct assessment of venous patency at the anastomotic site. By providing a consistent auditory signal corresponding to blood flow, FCs allow for early identification of venous occlusion, which is a common cause of flap failure. Their ability to function without the need for repeated manual assessments makes them particularly appealing in high-volume or resource-limited settings.10 Preliminary studies have reported promising outcomes with FCs, suggesting potential reductions in flap loss and faster detection and revision of vascular compromise.10,11 However, the existing literature is characterized by considerable heterogeneity in study design, sample size, flap types, and monitoring protocols, which hampers firm conclusions regarding their diagnostic accuracy and overall clinical utility. This systematic review critically appraised the current evidence on the use of FCs in microsurgical free flap reconstruction, focusing on their ability to detect early vascular compromise, their impact on flap salvage and survival, and their performance relative to established monitoring modalities. The aim was to define the clinical role of FCs and identify areas requiring further investigation to optimize postoperative flap monitoring. METHODS Literature Search The review was conducted in accordance with the PRISMA and meta-analysis of observational studies in epidemiology guidelines.12 A systematic literature search was independently performed by 2 authors (L.DP. and L.G.D.) in PubMed, Web of Science, and the Cochrane Library, including all records up to November 1, 2025. The search strategy was limited to the term “flow coupler,” as preliminary testing confirmed that broader Boolean combinations did not yield additional relevant studies. Related terms (eg, vascular, venous, or vein coupler, and Synovis) were excluded due to inconsistent device reference. Inclusion and exclusion criteria are shown in Table 2. All studies used comparable continuous Doppler-based venous outflow monitoring. Ethical approval was not required due to the nature of the study. Table 2.Literature Search CriteriaInclusion CriteriaExclusion CriteriaRandomized controlled trialsPreclinical studiesCase–control studiesEx vivo studiesProspective cohort studiesNarrative literature reviewsRetrospective cohort studiesStudies not involving free flap surgeryCase series including ≥5 patientsStudies not using an FC deviceUse of an implantable FC device for postoperative monitoring following free flap surgeryStudies not based on continuous venous outflow monitoring at the venous anastomotic siteContinuous Doppler-based monitoring of venous outflow via an integrated sensorStudies using non-Doppler or noncontinuous monitoring techniquesHuman clinical studiesNonhuman studiesEnglish-language publicationsNon–English-language publications Literature Search Criteria Data Extraction Two independent reviewers (L.DP. and L.G.D.) screened all titles and abstracts. Full texts of eligible studies were assessed, and exclusions were applied according to predefined criteria (Fig. 1). Disagreements were resolved by a third reviewer (C.Z.). Reference lists of included articles were screened for additional studies. PRISMA flow chart. Data extraction was performed using a standardized Excel sheet, recording study characteristics, flap type, survival and failure rates, venous thrombosis, complications, and quantitative FC performance (sensitivity, specificity, and flap failure), defined as the primary outcome. Flap failure was defined as complete loss of the free flap requiring removal, whereas vascular compromise with successful reexploration and partial flap necrosis not resulting in total flap loss were not classified as failures. Assessment of Risk of Bias and Quality of Evidence of the Included Studies Risk of bias was evaluated using the Methodological Index for Non-Randomized Studies (MINORS).13 (See table, Supplemental Digital Content 1, which displays the MINORS criteria, https://links.lww.com/PRSGO/E952.) Two authors (L.DP. and L.G.D.) performed independent assessments, and discrepancies were resolved with a third author (I.L.). Statistical Analysis The meta-sensitivity and meta-specificity of FC for detecting flap failure were calculated from 6 and 4 studies, respectively. Meta-flap failure rates for FC and non–flow coupler (NFC) groups were derived from 3 studies each. Comparative outcomes were pooled using a random-effects restricted maximum likelihood model and expressed as odds ratios with 95% confidence intervals. Statistical significance was defined as a P value less than 0.05. Heterogeneity was evaluated using forest plots and the I2 statistic. All analyses were performed with OpenMetaAnalyst. RESULTS Study Characteristics This systematic review encompasses 11 clinical studies published between 2012 and 2024, involving 1775 microsurgical free tissue transfers, of which 876 (49.3%) were monitored using implantable anastomotic venous FC systems. (See table, Supplemental Digital Content 2, which displays the included studies, https://links.lww.com/PRSGO/E953.) The sample includes single-center retrospective analyses,11,14 comparative prospective cohorts,10,15 and observational case series reporting consecutive reconstructions across multiple anatomical domains. The anatomical distribution of flaps spanned head and neck, breast, and extremity reconstructions, using tissue types such as fasciocutaneous (eg, radial forearm and anterior lateral thigh flap), musculocutaneous (eg, muscle-sparing transverse rectus abdominis myocutaneous and transverse-upper gracilis), and osteocutaneous flaps (eg, fibular and scapular). FC use was most frequently reported in buried flap scenarios, particularly in deep inferior epigastric perforator after nipple-sparing mastectomies and fibular flaps without a skin island, where conventional clinical monitoring is inherently limited. The predominant device model used was the Synovis (Synovis Micro Companies Alliance Inc, Birmingham, AL) venous FC, integrated into end-to-end venous anastomoses, enabling continuous, implantable Doppler-based signal acquisition. Comparator groups varied across studies, encompassing handheld Doppler,16 Cook-Swartz implantable probes,15 and standard noncoupler-based observation.11 Study periods ranged from brief observational windows of 18 months to extensive institutional experiences spanning more than 5 years. Flap Survival and Failure Rates Flap survival in FC-monitored reconstructions was consistently high across all studies, with reported success rates ranging from 94.6% to 99.1%. The lowest recorded survival rate (94.6%) was identified in a cohort involving buried head and neck flaps,11 whereas the highest rate (99.1%) was documented in a series encompassing 111 breast reconstructions. Bowe et al10 reported a survival rate of 98.6% in their FC-monitored group, notably, although not significantly, surpassing the 95.7% survival (P = 0.41) seen in their NFC cohort. Creasy et al,17 in a detailed analysis of 124 buried autologous breast flaps, identified equivalent survival rates between FC and NFC groups, although FCs were emphasized for their value in signal-based decision-making and aesthetic optimization through omission of external monitoring paddles. The comparative impact of FC monitoring on flap loss was less uniformly favorable. The study by Kempton et al16 demonstrated a slightly lower survival rate in FC-monitored flaps (95.8%) compared with those monitored with handheld Doppler (97.1%). However, this discrepancy was not statistically interrogated and may reflect patient selection or operator variability rather than intrinsic limitations of FC technology. Diagnostic Accuracy In studies that systematically evaluated diagnostic performance, FCs demonstrated excellent sensitivity in detecting venous thrombosis. Both Troob et al18 and Bowe et al10 reported 100% sensitivity, identifying all cases of venous compromise that necessitated surgical intervention. The cohort by Kempton et al16 further supported this finding, with negative predictive values of 1.0 for both intraoperative and postoperative monitoring phases, indicating that sustained signal presence is a highly reliable indicator of flap viability. However, the specificity and positive predictive value (PPV) of FCs were more modest. Kempton et al16 observed a specificity of 79.0% and an intraoperative PPV of only 36%, indicating that more than half of the signal loss events did not correlate with true thrombosis. Fujiwara et al19 similarly reported a false-positive rate of 13.6%, whereas Troob et al18 identified a rate of 5.1%. These figures highlight a consistent pattern: FCs are highly effective in ruling out vascular compromise when a signal is present but significantly less reliable in confirming it when a signal is absent. The study by Bowe et al10 stood as a notable exception, reporting a specificity and PPV of 100%, though the diagnostic criteria were stringent and the flap cohort was relatively limited. Meta-analysis Based on 6 studies including a total of 619 patients, the pooled sensitivity of FCs in detecting flap failure was 96.5% (SD 4.8%).10,11,15,16,18,19 In 4 studies comprising 484 patients, the pooled specificity of FCs for flap failure was calculated at 90.9% (SD 7.0%).10,16,18,19 Moreover, 3 studies with 268 patients reported a meta-flap failure rate of 2.2% (SD 1.7%) for FCs.10,15,16 In comparison, data from 3 studies, including 260 patients, indicated a meta-flap failure rate of 3.1% (SD 1.2%) for NFCs.10,15,16 Figure 2 shows the total number of flap failures among all flaps in the FC and NFC groups. The overall odds ratio was 0.630, indicating that the use of FCs was associated with fewer flap failures. However, no significant difference could be discerned. With an I2 of 0%, no statistically significant heterogeneity was observed between studies. The studies provide consistent results with a reliable pooled result.10,15,16 Forest plot. CI, confidence interval. Signal Loss and False-positive Events Signal attenuation or loss, defined as diminution or absence of the characteristic Doppler tone, emerged as a frequent occurrence across multiple studies. Kempton et al16 documented intraoperative signal loss in 29.4% of cases and postoperative loss in 13.2%, yet many of these events did not correspond to a thrombotic event. Similarly, Um et al15 reported 2 signal loss events (1.9%) that were ultimately classified as false positives after reexploration revealed patent venous anastomoses. In the series by Fujiwara et al,19 all signal loss events (13.6% in total) were of nonpathological origin, and Colakoglu et al20 further observed that intraoperative signal fluctuations did not invariably herald failure, although they often predicted higher complication rates. The cohort by Troob et al18 demonstrated a 5.1% rate of false-positive events, reinforcing the potential for overinterpretation of signal absence. By contrast, the series by Bowe et al,10 which applied rigorous definitions and postoperative validation, reported no false positives, suggesting that institutional protocol standardization and interpretative training can help minimize diagnostic errors. False-negative Events and Missed Compromises Instances of false negatives, wherein FC failed to detect venous occlusion, were overall rare. Among all included studies, only Troob et al18 reported 2 missed events in 217 FC-monitored flaps. The remainder, including Fujiwara et al,19 Um et al,15 Bowe et al,10 and Shtarbanov et al,21 documented no false-negative events, further supporting the high sensitivity of the technology. Comparative Efficacy Versus Alternative Modalities Four studies directly compared FCs to other monitoring approaches. Um et al15 found no significant difference in flap loss rates between FC and Cook-Swartz Doppler groups, both demonstrating high diagnostic reliability. Kempton et al16 reported a higher rate of signal loss in FC-monitored cases compared with handheld Doppler monitoring but found FCs to be advantageous for continuous surveillance. Chadwick et al11 emphasized the utility of FCs in buried flaps following nipple-sparing mastectomy. DISCUSSION The integration of venous FCs into microsurgical free tissue transfer represents a significant advancement in postoperative flap monitoring. By combining a microvascular anastomotic coupler with a 20-MHz Doppler transducer, FCs provide continuous real-time assessment of anastomotic venous outflow. Their application is particularly advantageous in buried flaps, in which conventional clinical evaluation of perfusion is limited or impossible. Across 11 clinical studies encompassing 1775 free flaps, FCs demonstrated consistently high diagnostic performance, with pooled sensitivity and specificity of 96.5% (SD 4.8%) and 90.9% (SD 7.0%), respectively. The meta-analysis further revealed a lower flap failure rate in FC-monitored cases (2.2%) compared with NFC flaps (3.1%), with a pooled odds ratio of 0.63 (95% confidence interval 0.17–2.33). Although this difference did not reach statistical significance, the absence of heterogeneity (I2 = 0%) underscores the reliability and consistency of the available evidence. These findings highlight the value of FCs as a sensitive and dependable tool for early detection of venous compromise in microsurgical reconstruction.12,15,16 However, the absence of a signal does not inherently imply flap failure, and herein lies the greatest interpretive challenge. The specificity and PPV of FCs remain modest, with considerable interstudy variability. Reports from Kempton et al,16 Fujiwara et al,19 and Colakoglu et al20 identified a false-positive rate of 5.1%–13.6% of signal loss events in monitored flaps—cases in which reexploration revealed patent venous anastomoses. These false positives, although valuable in prompting early intervention, carry the risk of unnecessary surgical take-backs, increased morbidity, and higher healthcare costs. Such findings highlight the need for cautious interpretation of FC signal loss, ideally in conjunction with clinical examination and other monitoring modalities. Encouragingly, Bowe et al10 demonstrated that rigorous protocolization, proper FC placement, and institutional experience can reduce false-positive rates. In their study, the PPV of FCs reached 100%, emphasizing that institutional learning curves and procedural standardization are critical to optimizing device reliability. Technical and intraoperative factors seem to be primary contributors to diagnostic variability and false alarms. Several studies, including those by Colakoglu et al20 and Kempton et al,16 identified intraoperative fluctuations in FC signal attributable to flap inset tension, kinking of venous pedicle, and improper wire positioning or trajectory. These nonvascular sources of signal loss can mimic thrombosis and precipitate reexploration. In complex reconstructions, such as bipedicled or folded flaps, Shtarbanov et al21 detailed additional mechanical pitfalls, including tension at the anastomotic site due to wire exit orientation. These complications highlight a critical aspect of FC utility: the importance of technical precision and surgical experience. Proper coupler sizing, pedicle routing, avoidance of sharp angulations, and careful flap inset are essential to maintain signal fidelity. The learning curve for consistent and reliable FC signal interpretation is steep and may explain some of the heterogeneity observed in published outcomes. The clinical value of FCs becomes particularly evident in buried or concealed flap reconstructions. In autologous breast reconstruction, for example, Creasy et al17 showed that the use of FCs allowed complete de-epithelialization of the flap and elimination of external monitoring paddles. This not only preserved the native breast skin envelope but also reduced patient burden and the number of surgical stages required to achieve the final reconstructive outcome. Similarly, in head and neck surgery, Troob et al18 demonstrated that FCs enabled early detection of venous thromboses before overt clinical signs emerged—preceding changes in arterial Doppler or flap appearance and facilitating successful salvage in all affected cases. These examples illustrate the ability of FC to provide consistent, operator-independent monitoring during the critical early postoperative period, thereby expanding the reconstructive surgeon’s monitoring capabilities in anatomically challenging cases.8 FCs are primarily designed to monitor venous outflow, as venous thrombosis represents the leading cause of free flap failure. Although cessation of arterial inflow should theoretically eliminate venous signal and allow indirect detection of arterial compromise, this assumption has not been consistently supported in practice. Bowe et al10 reported an arterial thrombosis–related flap loss undetected by the FC, suggesting that certain arterial events may not produce an immediate or discernible change in venous flow. Thus, although FCs reliably detect venous complications, their sensitivity to arterial insufficiency seems limited, reinforcing the value of multimodal flap monitoring. To address current limitations of FC monitoring—particularly the high rate of false-positive signal loss—structured management algorithms have been proposed to guide clinical decision-making. Signal attenuation or loss does not necessarily indicate venous thrombosis and is frequently related to technical factors such as venous pedicle kinking, wire tension or displacement, probe malposition, or transient changes in venous outflow. Isolated signal loss should therefore be interpreted cautiously and in conjunction with clinical assessment and adjunctive monitoring. Davis et al22 described a pragmatic bedside neck exploration algorithm for head and neck flaps that integrates FC findings with targeted clinical evaluation, thereby safely avoiding operative take-back in over half of cases without compromising flap survival. These findings underscore the importance of standardized institutional protocols, although their generalizability may be limited to resource-rich clinical environments. Another important aspect that warrants consideration is the potential for complications directly related to the use of the FC. Concerns have repeatedly been voiced regarding postoperative hematoma or secondary bleeding, as well as partial or total flap loss caused by anastomotic compromise, for instance, through traction on the coupler wire during the postoperative period. Interestingly, despite these apprehensions being frequently mentioned in clinical discussions, only a single case of questionable postremoval hematoma formation, as well as the correlation to a partial flap loss after FC removal, was reported.21 This paucity of evidence is noteworthy, as such risks often contribute to surgeons’ hesitation to adopt FCs more widely. The limited data may reflect either the rarity of these events or the lack of systematic reporting in the literature. To address these concerns, prospective multicenter studies and standardized registries are needed to define the true complication profile and strengthen evidence-based recommendations for FC use in microsurgical reconstruction. Overall, venous FCs represent a valuable addition to the microsurgical monitoring armamentarium, particularly in buried or high-risk flaps. Their high sensitivity and negative predictive value make them reliable for excluding venous compromise, although their indirect assessment of arterial flow, modest specificity, and susceptibility to technical artifacts necessitate integration within a multimodal monitoring strategy. Additional costs associated with device use—including potential downstream costs related to false-positive signal loss and reexploration—should be acknowledged. At present, robust cost-effectiveness data are lacking, partly due to the absence of a statistically significant reduction in flap loss rates. Consequently, the economic value of FCs is likely context dependent, and future studies should incorporate standardized economic endpoints to better define their cost–benefit profile. CONCLUSIONS FCs are highly sensitive and clinically valuable tools for monitoring venous outflow in microsurgical free flaps, particularly in buried reconstructions. Although flap loss rates were numerically lower in FC-monitored flaps, this difference did not reach statistical significance and must be interpreted cautiously. Their primary clinical value lies in early detection of venous compromise through high sensitivity and NPV, rather than in proven reduction of flap loss. However, moderate specificity and false-positive signal loss—often related to technical factors such as wire tension or flap geometry—may lead to unnecessary reexplorations. Integration within a multimodal monitoring strategy remains essential. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article. Supplementary Material